Breaking News Instant updates and real-time market news.

2020-12-01 07:35:09 PSTV Plus Therapeutics $2.13 / -0.01 (-0.47%) 07:35 12/01/20 12/01 07:35 12/01/20 07:35	Plus Therapeutics expands ReSPECT trial to MD Anderson Cancer Center Plus Therapeutics announced that the University of Texas MD Anderson Cancer Center is now an active clinical trial site in its ongoing ReSPECT Phase 1 clinical trial, currently supported by the National Cancer Institute. ReSPECT is a multi-center, dose-finding study evaluating the Company's lead investigational asset, Rhenium NanoLiposome, in patients with recurrent glioblastoma. The study will be conducted by MD Anderson's Department of Neurosurgery with Jeffrey Weinberg, M.D., Professor of Neurosurgery and the Deputy Chair and Vice-Chair of Clinical Operations in The Department of Neurosurgery, as primary investigator. As the Company previously disclosed, the sixth dose escalation cohort of the ReSPECT trial is underway and expected to enroll by the end of 2020. In September 2020, the U.S. Food and Drug Administration granted both Orphan Drug designation and Fast Track designation to RNL for the treatment of patients with glioblastoma.
PSTV Plus Therapeutics $2.13 / -0.01 (-0.47%) 10/16/20 Fly Intel: Top five analyst initiations 10/16/20 Maxim Plus Therapeutics initiated with a Buy at Maxim

2020-12-01 07:35:09

PSTV

Plus Therapeutics

$2.13 / -0.01 (-0.47%)

07:35

12/01/20

12/01

07:35

12/01/20

07:35

Plus Therapeutics expands ReSPECT trial to MD Anderson Cancer Center

Plus Therapeutics announced that the University of Texas MD Anderson Cancer Center is now an active clinical trial site in its ongoing ReSPECT Phase 1 clinical trial, currently supported by the National Cancer Institute. ReSPECT is a multi-center, dose-finding study evaluating the Company's lead investigational asset, Rhenium NanoLiposome, in patients with recurrent glioblastoma. The study will be conducted by MD Anderson's Department of Neurosurgery with Jeffrey Weinberg, M.D., Professor of Neurosurgery and the Deputy Chair and Vice-Chair of Clinical Operations in The Department of Neurosurgery, as primary investigator. As the Company previously disclosed, the sixth dose escalation cohort of the ReSPECT trial is underway and expected to enroll by the end of 2020. In September 2020, the U.S. Food and Drug Administration granted both Orphan Drug designation and Fast Track designation to RNL for the treatment of patients with glioblastoma.

PSTV Plus Therapeutics

$2.13 / -0.01 (-0.47%)

10/16/20: Fly Intel: Top five analyst initiations

10/16/20 Maxim: Plus Therapeutics initiated with a Buy at Maxim

TODAY'S FREE FLY STORIES

Upgrade	Morgan Stanley upgrades Gilead to Overweight at start of 'pivotal pipeline year' » 07:35 01/19/21 01/19 07:35 01/19/21 07:35 GILD Gilead $63.35 / +0.95 (+1.52%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GILD Gilead $63.35 / +0.95 (+1.52%) 01/12/21 Gilead, Vir Biotechnology establish collaboration for chronic HBV 01/12/21 Gilead, Vir collaborate to explore combination strategies for HBV cure 01/06/21 Kite, Oxford BioTherapeutics enter research collaboration 12/16/20 Kite granted conditional marketing authorization for Tecartus from EC GILD Gilead $63.35 / +0.95 (+1.52%) 06:01 Today Morgan Stanley Gilead upgraded to Overweight from Equal Weight at Morgan Stanley 01/11/21 Piper Sandler Piper says hard for Gilead investors to ascribe long-term value to Veklury 01/04/21 Guggenheim Gilead upgraded to Buy from Neutral at Guggenheim 12/22/20 Citi Gilead price target lowered to $72 from $75 at Citi GILD Gilead $63.35 / +0.95 (+1.52%) 01/11/21 Gilead raises FY20 adjusted EPS view to $6.98 - $7.08 from $6.25 - $6.60 10/28/20 Gilead sees core business gradually recovering in Q4 and into 1H21 10/28/20 Gilead narrows FY20 adjusted EPS view to $6.25-$6.60 from $6.25-$7.65 10/28/20 Gilead Sciences reports Q3 adjusted EPS $2.11, consensus $1.95 GILD Gilead $63.35 / +0.95 (+1.52%) 11/19/20 WHO urges doctors not to use Gilead's remdesivir for coronavirus, Bloomberg says 10/15/20 WHO study says Gilead's remdesivir has little impact on COVID mortality, FT says 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports 09/12/20 Gilead near deal to buy Immunomedics for over $20B, WSJ reports GILD Gilead $63.35 / +0.95 (+1.52%) 01/11/21 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers GILD Gilead $63.35 / +0.95 (+1.52%) 01/11/21 Gilead call volume above normal and directionally bullish 12/31/20 Unusually active option classes on open December 31st 12/01/20 Gilead call volume above normal and directionally bullish 11/23/20 Gilead put volume heavy and directionally bearish
Options	Unusual call flow in option market yesterday » 07:35 01/19/21 01/19 07:35 01/19/21 07:35 SLQT SelectQuote $23.55 / +0.98 (+4.34%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options SLQT SelectQuote $23.55 / +0.98 (+4.34%) 09/01/20 SelectQuote announces first partnership with primary care provider Iora Health 07/24/20 SelectQuote falls -19.1% 07/24/20 SelectQuote falls -11.5% SLQT SelectQuote $23.55 / +0.98 (+4.34%) 10/06/20 Credit Suisse Walmart entry shows attractiveness of insurance market, says Credit Suisse 10/06/20 Citi Walmart entry a 'significant competitive threat' to eHealth, says Citi 09/08/20 Credit Suisse SelectQuote price target lowered to $31 from $38 at Credit Suisse 07/01/20 SVB Leerink SVB Leerink bullish on Benefytt Technologies, initiates with an Outperform SLQT SelectQuote $23.55 / +0.98 (+4.34%) 11/05/20 SelectQuote raises FY21 revenue view to $840M-$880M from $775M-$815M 11/05/20 SelectQuote reports Q1 EPS 1c, consensus (4c) 09/09/20 SelectQuote sees FY21 revenue $775M-$815M, consensus $756.96M 09/09/20 SelectQuote reports Q4 EPS 13c, consensus 3c 21 May SLQT SelectQuote $23.55 / +0.98 (+4.34%) 09/10/20 Fly Intel: Pre-market Movers 09/09/20 Fly Intel: After-Hours Movers SLQT SelectQuote $23.55 / +0.98 (+4.34%) 01/15/21 SelectQuote call buyer as shares jump
Recommendations	AMN Healthcare price target raised to $81 from $72 at BMO Capital » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 AMN AMN Healthcare $72.10 / +0.075 (+0.10%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings AMN AMN Healthcare $72.10 / +0.075 (+0.10%) 11/06/20 Truist AMN Healthcare price target raised to $78 from $68 at Truist 11/06/20 Credit Suisse AMN Healthcare price target raised to $76 from $63 at Credit Suisse 10/08/20 BofA AMN Healthcare initiated with a Buy at BofA 08/07/20 BMO Capital AMN Healthcare price target raised to $65 from $50 at BMO Capital AMN AMN Healthcare $72.10 / +0.075 (+0.10%) 01/11/21 AMN Healthcare sees Q4 revenue $623M-$628M, consensus $584.45M 11/05/20 AMN Healthcare sees Q4 revenue $575M-$585M, consensus $549.71M 11/05/20 AMN Healthcare reports Q3 adjusted EPS 82c, consensus 69c 10/29/20 Notable companies reporting after market close
Earnings	Kforce expects EPS to exceed 78c per share, consensus 75c » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 KFRC Kforce $42.70 / -1.28 (-2.91%) Sees revenue exceeding… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly KFRC Kforce $42.70 / -1.28 (-2.91%) 01/04/21 Sidoti Kforce upgraded to Buy from Neutral at Sidoti 08/11/20 Truist Kforce price target raised to $35 from $30 at Truist 08/11/20 William Blair Kforce upgraded to Outperform from Market Perform at William Blair 05/28/20 Sidoti Kforce downgraded to Neutral from Buy at Sidoti KFRC Kforce $42.70 / -1.28 (-2.91%) 11/02/20 Kforce sees Q4 EPS 70c-78c,consensus 60c 11/02/20 Kforce reports Q3 EPS 89c, consensus 81c 09/21/20 Kforce raises Q3 EPS greater than 82c per share, consensus 76c 08/10/20 Kforce sees Q3 EPS 72c-80c, consensus 40c KFRC Kforce $42.70 / -1.28 (-2.91%) 09/21/20 Fly Intel: After-Hours Movers 08/10/20 Fly Intel: After-Hours Movers
Hot Stocks	Pembina Pipeline announces binding open season » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 PBA Pembina Pipeline $27.39 / -0.5 (-1.79%) Pembina Pipeline… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events PBA Pembina Pipeline $27.39 / -0.5 (-1.79%) 12/14/20 Pembina Pipeline sees FY21 CapEx $730M 12/14/20 Pembina Pipeline sees 2021 adjusted EBITDA $3.2B-$3.4B PBA Pembina Pipeline $27.39 / -0.5 (-1.79%) 01/13/21 CIBC Pembina Pipeline price target raised to C$40 from C$38 at CIBC 12/15/20 BMO Capital Pembina Pipeline downgraded to Market Perform from Outperform at BMO Capital 11/30/20 Wells Fargo Pembina Pipeline downgraded to Equal Weight from Overweight at Wells Fargo 11/19/20 Canaccord Pembina Pipeline price target lowered to C$40 from C$42 at Canaccord 02/26/21 Pembina Pipeline - PBA

Hot Stocks	Veritone, Base Media Cloud announce six-year agreement » 07:34 01/19/21 01/19 07:34 01/19/21 07:34 VERI Veritone $38.75 / -1.99 (-4.88%) Veritone with Base Media… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options VERI Veritone $38.75 / -1.99 (-4.88%) 01/11/21 Veritone announces strategic relationship with Alteryx 12/09/20 Veritone enters new content licensing agreement with Brave Bison 12/03/20 Veritone reports achievement of AWS Public Safety & Disaster Response Competency 11/19/20 Veritone receives three new patents for battery control technology VERI Veritone $38.75 / -1.99 (-4.88%) 12/21/20 Roth Capital Veritone price target raised to $31 from $20 at Roth Capital 12/21/20 Stifel Veritone initiated with a Hold at Stifel 11/19/20 Roth Capital Veritone price target raised to $20 from $18 at Roth Capital 10/06/20 Roth Capital Veritone energy suite adds to platform's use cases, says Roth Capital VERI Veritone $38.75 / -1.99 (-4.88%) 11/09/20 Veritone sees Q4 revenue $16M-$16.4M, consensus $14.95M 11/09/20 Veritone reports Q3 EPS (15c), consensus (20c) 08/10/20 Veritone sees Q3 revenue $14.2M-$14.6M, consensus $13.3M 08/10/20 Veritone reports Q2 adjusted EPS (21c), consensus (23c) 03 Dec VERI Veritone $38.75 / -1.99 (-4.88%) 12/02/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference VERI Veritone $38.75 / -1.99 (-4.88%) 12/07/20 Largest borrow rate increases among liquid names
Initiation	Skillz platform accelerates, Canacord initiates with Buy » 07:33 01/19/21 01/19 07:33 01/19/21 07:33 SKLZ Skillz $24.81 / -1.23 (-4.72%) As reported previously,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SKLZ Skillz $24.81 / -1.23 (-4.72%) 06:37 Today Canaccord Skillz initiated with a Buy at Canaccord 01/15/21 Fly Intel: Top five analyst initiations 01/15/21 Wells Fargo Skillz initiated with an Equal Weight at Wells Fargo 01/12/21 Wedbush Skillz initiated with an Outperform at Wedbush
Hot Stocks	Accuray reports data from phase II trial using TomoTherapy System » 07:32 01/19/21 01/19 07:32 01/19/21 07:32 ARAY Accuray $4.76 / -0.2 (-4.03%) Accuray announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ARAY Accuray $4.76 / -0.2 (-4.03%) 01/05/21 Accuray receives FDA clearance for its Helical kVCT Imaging 11/18/20 Accuray, DHL Supply Chain enter logistics partnership 11/12/20 Accuray director Whitters buys 50,000 shares 10/28/20 Accuray signs agreement with Brainlab to expand Cyberknife treatment ARAY Accuray $4.76 / -0.2 (-4.03%) 01/07/21 Fly Intel: Top five analyst initiations 01/07/21 Northland Accuray initiated with an Outperform at Northland 09/28/20 Lake Street CMS 'pouring fuel on the fire' for Accuray with APM rule, says Lake Street 09/18/20 Cowen New CMS model should provide tailwind for Accuray, says Cowen ARAY Accuray $4.76 / -0.2 (-4.03%) 10/29/20 Accuray reports Q1 EPS 0c, consensus (7c) 08/13/20 Accuray not providing FY21 guidance 08/13/20 Accuray reports Q4 EPS (1c), consensus (2c) ARAY Accuray $4.76 / -0.2 (-4.03%) 10/29/20 Fly Intel: After-Hours Movers 08/13/20 Fly Intel: After-Hours Movers 01/27/21 Accuray - ARAY
Earnings	FMC Corporation cuts Q4 revenue view to about $1.15B from $1.23B-$1.29B » 07:32 01/19/21 01/19 07:32 01/19/21 07:32 FMC FMC Corporation $120.03 / -1.69 (-1.39%) Q4 consensus $1.26B. FMC… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events FMC FMC Corporation $120.03 / -1.69 (-1.39%) 12/02/20 FMC Corporation raises dividend by 9% to 48c per share 11/02/20 FMC Corporation sees FY20 free cash flow $475M-$525M 10/26/20 FMC Corporation names Dr. Karen Totland as chief sustainability officer 08/20/20 FMC Corporation partnering with Zymergen for crop protection technology FMC FMC Corporation $120.03 / -1.69 (-1.39%) 11/20/20 Fly Intel: Top five analyst initiations 11/20/20 Bernstein FMC Corporation initiated with a Market Perform at Bernstein 11/18/20 BMO Capital FMC Corporation price target raised to $124 from $120 at BMO Capital 11/18/20 KeyBanc FMC Corporation price target raised to $137 from $121 at KeyBanc FMC FMC Corporation $120.03 / -1.69 (-1.39%) 11/02/20 FMC Corporation sees Q4 adjusted EPS $1.70-$1.82, consensus $1.82 11/02/20 FMC Corporation narrows FY20 adjusted EPS view to $6.45 -$6.57 from $6.28-$6.62 11/02/20 FMC Corporation reports Q3 adjusted EPS $1.22, consensus $1.11 11/02/20 Notable companies reporting after market close 02/10/21 FMC Corporation - FMC
Recommendations	Snap price target raised to $60 from $40 at KeyBanc » 07:31 01/19/21 01/19 07:31 01/19/21 07:31 SNAP Snap $50.29 / +1.245 (+2.54%) KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SNAP Snap $50.29 / +1.245 (+2.54%) 12/29/20 Snap rises 10.1% 12/17/20 Snap CFO sells 56.8K shares of common stock 12/17/20 Unity, Snap announce partnership to extend advertising, technology reach 12/14/20 FTC seeking data from Facebook, other social media and streaming services SNAP Snap $50.29 / +1.245 (+2.54%) 01/15/21 Fly Intel: Top five analyst upgrades 01/15/21 MoffettNathanson Snap upgraded to Buy with $57 price target at MoffettNathanson 01/15/21 MoffettNathanson Snap upgraded to Buy from Neutral at MoffettNathanson 01/12/21 Cowen Snap price target raised to $62 from $45 at Cowen SNAP Snap $50.29 / +1.245 (+2.54%) 10/20/20 Snap says 47%-50% year-over-year revenue growth in Q4 'attainable' 10/20/20 Snap reports Q3 adjusted EPS 1c, consensus (5c) 10/20/20 Notable companies reporting after market close 07/21/20 Snap not providing Q3 revenue, adjusted EBITDA guidance SNAP Snap $50.29 / +1.245 (+2.54%) 01/13/21 Snap to permanently suspend Trump's Snapchat account, Reuters says 01/11/21 Snap confirms acquisition of start-up StreetCred, TechCrunch reports 01/04/21 Google, Snap in advanced discussions to invest in ShareChat, TechCrunch reports 12/14/20 FTC to launch sweeping privacy study of Amazon, Facebook, Axios says SNAP Snap $50.29 / +1.245 (+2.54%) 10/21/20 Pinterest jumps as analysts say buy after Snap earnings beat 10/21/20 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: After-Hours Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 02/23/21 Snap Inc. SNAP Snap $50.29 / +1.245 (+2.54%) 01/11/21 Unusually active option classes on open January 11th 01/07/21 Snap Inc. call volume above normal and directionally bullish 12/30/20 Unusually active option classes on open December 30th 12/29/20 Unusually active option classes on open December 29th

Hot Stocks	Federal court dismisses class action lawsuit against 22nd Century » 07:31 01/19/21 01/19 07:31 01/19/21 07:31 XXII 22nd Century $2.77 / -0.05 (-1.77%) 22nd Century Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings XXII 22nd Century $2.77 / -0.05 (-1.77%) 01/11/21 22nd Century to expand VLN Tobacco growing program 12/08/20 22nd Century receives order for 3.6M SPECTRUM variable nicotine cigarettes 11/05/20 22nd Century says 'intensified its proactive efforts' to secure MRTP 10/14/20 22nd Century announces grant of new U.S. patent related to nicotine reduction XXII 22nd Century $2.77 / -0.05 (-1.77%) 11/05/20 22nd Century reports Q3 EPS (3c), one estimate (4c) 08/06/20 22nd Century reports Q2 EPS (4c) vs. (6c) a year ago
Recommendations	Assurant price target raised to $170 from $150 at Truist » 07:30 01/19/21 01/19 07:30 01/19/21 07:30 AIZ Assurant $31.00 / +15 (+9.00%) Truist analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events Options AIZ Assurant $31.00 / +15 (+9.00%) 01/12/21 Assurant announces new $600M share repurchase plan 12/17/20 Assurant acquires EPG Insurance for $43M in cash 11/11/20 Assurant raises quarterly dividend 5% to 66c per share 10/28/20 Assurant acquires HYLA Mobile in $325M transaction AIZ Assurant $31.00 / +15 (+9.00%) 11/02/20 Assurant raises FY20 adj. net income growth view to 17%-21% from 12%-16% 11/02/20 Assurant reports Q3 ops EPS $1.41, consensus $1.00 08/04/20 Assurant sees 2020 adjusted net income up 12%-16% from 2019 08/04/20 Assurant reports Q2 EPS $2.75, consensus $2.09 02/10/21 Assurant - AIZ AIZ Assurant $31.00 / +15 (+9.00%) 08/05/20 Early notable gainers among liquid option names on August 5th
Recommendations	Pinterest price target raised to $86 from $76 at KeyBanc » 07:30 01/19/21 01/19 07:30 01/19/21 07:30 PINS Pinterest / + KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PINS Pinterest / + 12/17/20 Pinterest pledges changes to workplace culture after discrimination settlement 12/01/20 AudioEye announces Rob Ulveling as chief business officer 10/29/20 Pinterest rises 30.2% 10/29/20 Pinterest rises 38.1% PINS Pinterest / + 01/08/21 Baird Pinterest price target raised to $80 from $68 at Baird 01/05/21 Morgan Stanley Pinterest price target raised to $80 from $73 at Morgan Stanley 01/05/21 Morgan Stanley Facebook price target raised to $340 from $315 at Morgan Stanley 12/17/20 Fly Intel: Top five analyst initiations PINS Pinterest / + 10/28/20 Pinterest sees Q4 revenue up 60 from last year 10/28/20 Pinterest reports Q3 EPS 13c, consensus 2c 10/28/20 Notable companies reporting after market close 07/31/20 Pinterest not providing FY20 guidance due to COVID-19 PINS Pinterest / + 12/15/20 Pinterest to pay $22.5M to settle gender discrimination suit, NY Times reports 12/01/20 Pinterest holders sue company over alleged culture of discrimination, Verge says 08/12/20 Former Pinterest COO accuses company of gender bias in suit, NY Times reports PINS Pinterest / + 10/29/20 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers 10/21/20 Pinterest jumps as analysts say buy after Snap earnings beat 10/21/20 Fly Intel: Pre-market Movers PINS Pinterest / + 12/31/20 Pinterest call buyer realizes 4% same-day gains 12/30/20 Pinterest call volume above normal and directionally bullish 12/23/20 Pinterest call volume above normal and directionally bullish 10/30/20 Unusually active option classes on open October 30th
Downgrade	Restaurant Brands downgraded to Equal Weight from Overweight at Morgan Stanley » 07:30 01/19/21 01/19 07:30 01/19/21 07:30 QSR Restaurant Brands $62.80 / -1.41 (-2.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options QSR Restaurant Brands $62.80 / -1.41 (-2.20%) 12/11/20 Restaurant Brands recommends holders reject TRC Capital's 'mini-tender offer' 11/19/20 Pershing Square sees improving business fundamentals at Restaurant Brands 10/27/20 Restaurant Brands to modernize over 10,000 Burger King, Tim Hortons drive-thrus 10/22/20 Restaurant Brands' Burger King brand to pilot reusable containers QSR Restaurant Brands $62.80 / -1.41 (-2.20%) 05:18 Today Goldman Sachs Restaurant Brands initiated with a Sell at Goldman Sachs 01/15/21 BMO Capital Restaurant Brands price target raised to $70 from $65 at BMO Capital 01/12/21 Baird Baird cautious Restaurant Brands ahead of results 01/07/21 Stephens Restaurant Brands upgraded to Overweight on rotation expectations at Stephens QSR Restaurant Brands $62.80 / -1.41 (-2.20%) 10/27/20 Restaurant Brands reports Q3 EPS 47c, consensus 56c 10/26/20 Notable companies reporting before tomorrow's open 10/26/20 Notable companies reporting before tomorrow's open 10/14/20 Restaurant Brands sees Q3 revenue$1.32B-$1.34B consensus $1.15B QSR Restaurant Brands $62.80 / -1.41 (-2.20%) 01/07/21 Restaurant Brands' Burger King redesigns brand, Reuters reports 01/04/21 McDonald's to launch 3 new chicken sandwiches in U.S. in February, Reuters says QSR Restaurant Brands $62.80 / -1.41 (-2.20%) 08/17/20 Unusually active option classes on open August 17th
Hot Stocks	Helius Medical regains compliance with Nasdaq listing standards » 07:30 01/19/21 01/19 07:30 01/19/21 07:30 HSDT Helius Medical $15.39 / -0.36 (-2.29%) Helius Medical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News On The Fly Events HSDT Helius Medical $15.39 / -0.36 (-2.29%) 01/11/21 Helius Medical submits response to FDA regarding PoNS device clearance 01/06/21 Helius Medical Technologies Inc trading resumes 01/06/21 Helius Medical Technologies Inc trading halted, volatility trading pause 01/05/21 Helius Medical comments on 'unusual' trading activity HSDT Helius Medical $15.39 / -0.36 (-2.29%) 01/05/21 Fly Intel: After-Hours Movers 00:00 Today 17th Annual Small & Microcap Virtual Investor Conference

Hot Stocks	Goldman Sachs committed to medium-, long-term targets » 07:29 01/19/21 01/19 07:29 01/19/21 07:29 GS Goldman Sachs $301.05 / -6.95 (-2.26%) Medium-term targets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $301.05 / -6.95 (-2.26%) 07:28 Today Goldman Sachs CEO: 2020 a 'challenging year on many fronts' 07:27 Today Goldman Sachs reports Q4 ROE 21.1%, ROTE 22.5% 07:26 Today Goldman Sachs reports Q4 trading revenue $4.27B 01/05/21 IBM appoints Gary Cohn as Vice Chairman GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities 01/11/21 Piper Sandler Goldman Sachs price target raised to $325 from $270 at Piper Sandler 01/06/21 Deutsche Bank Goldman Sachs price target raised to $290 from $230 at Deutsche Bank 01/05/21 Wells Fargo Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo GS Goldman Sachs $301.05 / -6.95 (-2.26%) 07:25 Today Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $301.05 / -6.95 (-2.26%) 10/14/20 Fly Intel: Pre-market Movers 09/04/20 Fly Intel: Pre-market Movers 07/24/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/24/21 REITwise 2021 Virtual Conference 09:30 Today Goldman Sachs - GS GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Hot Stocks	Clene Nanomedicine receives notice of allowance for use of gold nanocrystals » 07:28 01/19/21 01/19 07:28 01/19/21 07:28 CLNN Clene Nanomedicine $6.60 / -0.3 (-4.35%) Clene announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial
Recommendations	Nevro price target raised to $203 from $167 at Canaccord » 07:28 01/19/21 01/19 07:28 01/19/21 07:28 NVRO Nevro $175.11 / -0.555 (-0.32%) Canaccord raised the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals Events NVRO Nevro $175.11 / -0.555 (-0.32%) 07:09 Today Nevro announces data supporting use of HF10 therapy 12/28/20 Nevro announces FDA submission for HF10 in PDN patients 12/14/20 Boston Scientific says stipulation of dismissal filed in Nevro patent case 12/14/20 Nevro to conclude its Boston Scientific lawsuit in DC area NVRO Nevro $175.11 / -0.555 (-0.32%) 01/06/21 Truist Nevro price target raised to $205 from $175 at Truist 01/05/21 Baird Nevro price target raised to $200 from $180 at Baird 01/04/21 Wells Fargo Nevro price target raised to $215 from $177 at Wells Fargo 12/31/20 Guggenheim Nevro price target raised to $205 from $190 at Guggenheim NVRO Nevro $175.11 / -0.555 (-0.32%) 01/11/21 Nevro sees FY20 revenue $362M, consensus $358.76M 01/11/21 Nevro sees Q4 revenue $109.7M, consensus $106.54M 11/05/20 Nevro reports Q3 EPS (29c), consensus (59c) 08/05/20 Nevro reports Q2 EPS ($1.21), consensus ($1.62) 02 Apr NVRO Nevro $175.11 / -0.555 (-0.32%) 01/07/21 Nevro named a short idea, accused of fraud by Scorpion Capital 02/24/21 Nevro - NVRO
Hot Stocks	Goldman Sachs CEO: 2020 a 'challenging year on many fronts' » 07:28 01/19/21 01/19 07:28 01/19/21 07:28 GS Goldman Sachs $38.00 / +20 (+7.00%) Chairman and CEO David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $38.00 / +20 (+7.00%) 07:27 Today Goldman Sachs reports Q4 ROE 21.1%, ROTE 22.5% 07:26 Today Goldman Sachs reports Q4 trading revenue $4.27B 01/05/21 IBM appoints Gary Cohn as Vice Chairman 12/20/20 Fly Intel: Top five weekend stock stories GS Goldman Sachs $38.00 / +20 (+7.00%) 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities 01/11/21 Piper Sandler Goldman Sachs price target raised to $325 from $270 at Piper Sandler 01/06/21 Deutsche Bank Goldman Sachs price target raised to $290 from $230 at Deutsche Bank 01/05/21 Wells Fargo Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo GS Goldman Sachs $38.00 / +20 (+7.00%) 07:25 Today Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $38.00 / +20 (+7.00%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $38.00 / +20 (+7.00%) 10/14/20 Fly Intel: Pre-market Movers 09/04/20 Fly Intel: Pre-market Movers 07/24/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/24/21 REITwise 2021 Virtual Conference 09:30 Today Goldman Sachs - GS GS Goldman Sachs $38.00 / +20 (+7.00%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Recommendations	Facebook price target raised to $345 from $340 at KeyBanc » 07:28 01/19/21 01/19 07:28 01/19/21 07:28 FB Facebook $251.42 / +5.6 (+2.28%) , TWTR Twitter $45.18 / -0.62 (-1.35%) KeyBanc analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FB TWTR FB Facebook $251.42 / +5.6 (+2.28%) 01/11/21 Facebook to remove content containing phrase 'stop the steal' 01/11/21 Airbnb says its PAC will 'withhold support' from those who opposed certification 01/11/21 Facebook names Roy Austin as VP of Civil RIghts, deputy general counsel 01/10/21 Fly Intel: Top five weekend stock stories TWTR Twitter $45.18 / -0.62 (-1.35%) 01/13/21 Twitter CEO says @realDonaldTrump ban 'right decision' for company 01/11/21 Twitter suspends over 70,000 accounts since Friday 01/11/21 Twitter falls -10.1% 01/11/21 Twitter falls -11.3% FB TWTR FB Facebook $251.42 / +5.6 (+2.28%) 05:02 Today BMO Capital Facebook upgraded to Outperform from Market Perform at BMO Capital 01/15/21 MoffettNathanson Facebook price target raised to $325 from $285 at MoffettNathanson 01/12/21 Cowen Facebook price target raised to $340 from $330 at Cowen 01/11/21 Cowen Twilio powers new user verification for popular Signal app, says Cowen TWTR Twitter $45.18 / -0.62 (-1.35%) 01/13/21 Fly Intel: Top five analyst upgrades 01/13/21 MKM Partners Twitter upgraded to Buy from Neutral at MKM Partners 01/13/21 MKM Partners Twitter upgraded to Buy from Neutral at MKM Partners 01/12/21 Wells Fargo Wells cuts Twitter target to $43, says Trump 'will not be easily replaced' FB TWTR FB Facebook $251.42 / +5.6 (+2.28%) 10/29/20 Facebook sees Q4 ad revenue growth rate higher than Q3 10/29/20 Facebook reports Q3 EPS $2.71, consensus $1.91 10/29/20 Notable companies reporting after market close 07/30/20 Facebook reports Q2 EPS $1.80, consensus $1.39 TWTR Twitter $45.18 / -0.62 (-1.35%) 10/29/20 Twitter reports Q3 adjusted EPS 19c, consensus 6c 10/29/20 Notable companies reporting after market close 07/23/20 Twitter reports Q2 adjusted EPS (16c), consensus 0c 07/22/20 Notable companies reporting before tomorrow's open FB TWTR FB Facebook $251.42 / +5.6 (+2.28%) 06:08 Today WhatsApp delaying privacy policy by three months, The Verge reports 01/17/21 Facebook to ban ads promoting weapon accessories, protective gear, Reuters says 01/15/21 BlackBerry reports settlement with Facebook over patents, Bloomberg says 01/15/21 Facebook files suit against Chrome extension makers, Bleeping Computer says TWTR Twitter $45.18 / -0.62 (-1.35%) 01/10/21 Airbnb Section 230 use underscores law's reach beyond Facebook, WSJ says 01/08/21 Twitter staff demand CEO permanently suspend Trump account, WaPo says 01/08/21 Twitter bans accounts dedicated to sharing QAnon content, CNBC reports 01/08/21 Twitter blocks Sci-Hub account, Verge says FB TWTR FB Facebook $251.42 / +5.6 (+2.28%) 01/11/21 Twitter seen at more risk than Facebook from Trump bans 10/29/20 Fly Intel: After-Hours Movers 10/15/20 Twitter, Facebook in Republican crosshairs after actions on NY Post Biden story 10/07/20 House subcommittee report finds monopoly power, hints at Big Tech breakup TWTR Twitter $45.18 / -0.62 (-1.35%) 01/11/21 Twitter seen at more risk than Facebook from Trump bans 01/11/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: After-Hours Movers 01/20/21 Aesthetics Tech Virtual Summit 2021 02/11/21 Technology & Internet Virtual Conference 01/27/21 Facebook - FB 02/09/21 Twitter - TWTR 02/25/21 Twitter, Inc. FB TWTR FB Facebook $251.42 / +5.6 (+2.28%) 01/15/21 Facebook call volume above normal and directionally bullish 12/21/20 Facebook call buyer realizes 33% same-day gains 12/10/20 Unusually active option classes on open December 10th 12/07/20 Facebook call volume above normal and directionally bullish TWTR Twitter $45.18 / -0.62 (-1.35%) 01/12/21 Notable open interest changes for January 12th 12/14/20 Twitter call volume above normal and directionally bullish 12/11/20 Notable open interest changes for December 11th 10/30/20 Notable open interest changes for October 30th

Hot Stocks	Goldman Sachs reports Q4 ROE 21.1%, ROTE 22.5% » 07:27 01/19/21 01/19 07:27 01/19/21 07:27 GS Goldman Sachs $301.05 / -6.95 (-2.26%) Reports Q4 book value per… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $301.05 / -6.95 (-2.26%) 07:26 Today Goldman Sachs reports Q4 trading revenue $4.27B 01/05/21 IBM appoints Gary Cohn as Vice Chairman 12/20/20 Fly Intel: Top five weekend stock stories 12/18/20 Goldman Sachs to resume share repurchases next quarter GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities 01/11/21 Piper Sandler Goldman Sachs price target raised to $325 from $270 at Piper Sandler 01/06/21 Deutsche Bank Goldman Sachs price target raised to $290 from $230 at Deutsche Bank 01/05/21 Wells Fargo Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo GS Goldman Sachs $301.05 / -6.95 (-2.26%) 07:25 Today Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $301.05 / -6.95 (-2.26%) 10/14/20 Fly Intel: Pre-market Movers 09/04/20 Fly Intel: Pre-market Movers 07/24/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/24/21 REITwise 2021 Virtual Conference 09:30 Today Goldman Sachs - GS GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Hot Stocks	Climb Channel Solutions partners with ChannelOnline » 07:27 01/19/21 01/19 07:27 01/19/21 07:27 WSTG Wayside Technology $19.29 / +0.53 (+2.83%) Climb Channel Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News WSTG Wayside Technology $19.29 / +0.53 (+2.83%) 01/12/21 TechXtend, Resiliency Technologies announce national partnership 12/14/20 Climb Channel Solutions appoints Charles Bass as CMO 12/03/20 Climb Channel Solutions to distribute SUSE's open source solutions 11/09/20 Wayside Technology acquires CDF Group for $17.4M
Upgrade	Morgan Stanley upgrades Darden to Overweight on potential for dining out surge » 07:26 01/19/21 01/19 07:26 01/19/21 07:26 DRI Darden $121.10 / -2 (-1.62%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options DRI Darden $121.10 / -2 (-1.62%) 12/23/20 Darden VP Douglas Milanes sells almost $1.3M in company shares 12/18/20 Darden CEO says delivered 'strong profitability' in 'unpredictable environment' 12/18/20 Darden backs FY outlook for 35-40 net new restaurants 12/18/20 Darden elects CEO Eugene Lee, Jr. as Chairman of Board, succeeding Sonsteby DRI Darden $121.10 / -2 (-1.62%) 06:06 Today Morgan Stanley Darden upgraded to Overweight from Equal Weight at Morgan Stanley 05:21 Today Goldman Sachs Darden initiated with a Buy at Goldman Sachs 12/23/20 Argus Darden price target raised to $130 from $115 at Argus 12/21/20 KeyBanc Darden price target raised to $130 from $124 at KeyBanc DRI Darden $121.10 / -2 (-1.62%) 12/18/20 Darden sees Q3 EPS 50c-75c, consensus $1.34 12/18/20 Darden reports Q2 diluted EPS 74c, consensus 71c 12/17/20 Notable companies reporting before tomorrow's open 12/17/20 Notable companies reporting before tomorrow's open 21 Apr DRI Darden $121.10 / -2 (-1.62%) 12/18/20 Fly Intel: Pre-market Movers 09/24/20 Fly Intel: Pre-market Movers 09/01/20 Fly Intel: Pre-market Movers DRI Darden $121.10 / -2 (-1.62%) 12/01/20 Largest borrow rate increases among liquid names 09/29/20 Darden put volume heavy and directionally bearish 09/25/20 Darden put volume heavy and directionally bearish 09/24/20 Early notable gainers among liquid option names on September 24th
Hot Stocks	Goldman Sachs reports Q4 trading revenue $4.27B » 07:26 01/19/21 01/19 07:26 01/19/21 07:26 GS Goldman Sachs $301.05 / -6.95 (-2.26%) Net revenues in Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/05/21 IBM appoints Gary Cohn as Vice Chairman 12/20/20 Fly Intel: Top five weekend stock stories 12/18/20 Goldman Sachs to resume share repurchases next quarter 12/18/20 Fed to extend current restrictions on distributions with modifications GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities 01/11/21 Piper Sandler Goldman Sachs price target raised to $325 from $270 at Piper Sandler 01/06/21 Deutsche Bank Goldman Sachs price target raised to $290 from $230 at Deutsche Bank 01/05/21 Wells Fargo Goldman Sachs shares to pass all-time high 'soon,' says Wells Fargo GS Goldman Sachs $301.05 / -6.95 (-2.26%) 07:25 Today Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $301.05 / -6.95 (-2.26%) 10/14/20 Fly Intel: Pre-market Movers 09/04/20 Fly Intel: Pre-market Movers 07/24/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/24/21 REITwise 2021 Virtual Conference 09:30 Today Goldman Sachs - GS GS Goldman Sachs $301.05 / -6.95 (-2.26%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Recommendations	Biohaven Pharmaceutical price target lowered to $101 from $110 at Canaccord » 07:26 01/19/21 01/19 07:26 01/19/21 07:26 BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) Canaccord analyst Sumant… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 01/18/21 Biohaven's troriluzole did not differentiate from placebo in Alzheimer's trial 01/07/21 Biohaven Pharmaceutical acquires Kleo Pharmaceuticals, forms Biohaven Labs 01/04/21 Biohaven Pharmaceutical starts Phase 3 Trial of troriluzole in OCD 12/16/20 Biohaven's rimegepant shows efficacy and safety for migraine in Phase 3 trial BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 06:56 Today Mizuho Biohaven Pharmaceutical price target lowered to $93 from $100 at Mizuho 06:22 Today H.C. Wainwright Biohaven price target lowered to $111 from $121 at H.C. Wainwright 04:54 Today Piper Sandler Biohaven should pull back to mid-$70's on Alzheimer's miss, says Piper Sandler 12/29/20 Cantor Fitzgerald Biohaven price target raised to $115 from $109 at Cantor Fitzgerald BHVN Biohaven Pharmaceutical $84.76 / -7.065 (-7.69%) 11/09/20 Biohaven Pharmaceutical reports Q3 adj. EPS ($2.67), consensus ($2.89) 08/10/20 Biohaven Pharmaceutical reports Q2 non-GAAP EPS ($2.55), consensus ($2.61) 29 Jan

Events

Earnings calls, analyst events, roadshows and more

CMA
Today at 08:00

Comerica - CMA Conference Calls
PETS
Today at 08:00

PetMed Express - PETS Conference Calls
BAC
Today at 08:30

Bank of America - BAC Conference Calls
LOGI
Today at 08:30

Logitech - LOGI Conference Calls
HAL
Today at 09:00

Halliburton - HAL Conference Calls
EPAC
Today at 09:00

Enerpac Tool Group Corp Firm Sponsored Meetings

N86 W12500 Westbrook Crossing, Menomonee Falls, WI
OACB
Today at 09:00

OAKTREE ACQUISITION CORP. II Firm Sponsored Meetings

New York, NY
Today at 09:00

Healthcare Industry Meetings
GS
Today at 09:30

Goldman Sachs - GS Conference Calls
Today at 10:00

Board of Directors Meeting Government Event

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $16.00-18.00 15.647M Shares
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares
Fri	No deals

View All Syndicate Announcements »

Plus Therapeutics expands ReSPECT trial to MD Anderson Cancer Center

TODAY'S FREE FLY STORIES

Get Full Fly Access